Analysts Changed Share Price Targets on These Companies Dec 21st

Stock analysts reiterated their stock ratings on these companies today:

SXC Health Solutions (NASDAQ:SXCI): Maxim Group reiterated its rating of Buy for this company and changed its price target from $64 to $71. About the company: SXC Health Solutions Corporation provides pharmacy benefits management (AMEX:PBM) services and healthcare IT solutions to the healthcare benefits management industry. The Company’s product offerings and solutions combine a wide range of software applications, application service provider (NYSE:ASP) processing services, and professional services. Get the most recent company news and stock data here >>

Lincoln Electric (NASDAQ:LECO): Longbow reiterated its rating of Buy for this company and changed its price target from $40 to $44. About the company: Lincoln Electric Holdings, Inc. designs and manufactures welding and cutting products. The Company’s products include arc welding power sources, wire feeding systems, robotic welding packages, fume extraction equipment, consumable electrodes, fluxes, and regulators and torches used in oxy-fuel welding and cutting. Get the most recent company news and stock data here >>

Oracle (NASDAQ:ORCL): Macquarie reiterated its rating of Outperform for this company and changed its price target from $36 to $32. BMO Capital Markets reiterated its rating of Outperform for this company and changed its price target from $38 to $32. Collins Stewart reiterated its rating of Neutral for this company and changed its price target from $33 to $30. Ticonderoga reiterated its rating of Buy for this company and changed its price target from $38 to $34. About the company: Oracle Corporation supplies software for enterprise information management. The Company offers databases and relational servers, application development and decision support tools, and enterprise business applications. Oracle’s software runs on network computers, personal digital assistants, set-top devices, PCs, workstations, minicomputers, mainframes, and massively parallel computers. Get the most recent company news and stock data here >>

Body Central (NASDAQ:BODY): Avondale reiterated its rating of Mkt Outperform for this company and changed its price target from $26 to $30. About the company: Body Central Corp. is a multi-channel, specialty retailer. The Company operates speciality stores as well as has catalog sales and and e-commerce website. Body Central targets women in their late teens and twenties from diverse cultural backgrounds. The Company sells tops, dresses, bottoms, jewelry, accessories and shoes. Get the most recent company news and stock data here >>

First Solar (NASDAQ:FSLR): Brigantine reiterated its rating of Buy for this company and changed its price target from $60 to $40. About the company: First Solar, Inc. designs and manufactures solar modules. The Company uses a thin film semiconductor technology to manufacture electricity-producing solar modules. Get the most recent company news and stock data here >>

CVS Caremark (NYSE:CVS): Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $44 to $46. About the company: CVS Caremark Corporation is an integrated pharmacy health care provider. The Company’s offerings include pharmacy benefit management services; mail order, retail and specialty pharmacy; disease management programs; and retail clinics. The company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico. Get the most recent company news and stock data here >>

AtriCure (NASDAQ:ATRC): Kaufman Bros reiterated its rating of Buy for this company and changed its price target from $14 to $16. About the company: AtriCure, Inc. develops, manufactures, and sells surgical devices designed to create precise lesions in soft tissues. The Company’s bipolar ablation system is used by cardiothoracic surgeons as a standard treatment alternative to create lesions in heart tissue to block the abnormal electrical impulses that cause atrial fibrillation. Get the most recent company news and stock data here >>

Allot Comms (NASDAQ:ALLT): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $18 to $20. About the company: Allot Communications Ltd. designs and develops broadband service optimization solutions using advanced deep packet inspection (DPI) technology. The Company provides their customers with real-time highly granular visibility into network traffic and enables them to effectively manage and optimize their networks. Get the most recent company news and stock data here >>

C.R. Bard (NYSE:BCR): Mizuho reiterated its rating of Neutral for this company and changed its price target from $80 to $75. About the company: C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices. The Company sells a broad range of products worldwide to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. Bard markets vascular, urological, oncological, and surgical specialties products. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>